Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CD69 overexpression
i
Other names:
CD69 Molecule, CLEC2C, CD69 Antigen (P60, Early T-Cell Activation Antigen), Early T-Cell Activation Antigen P60, Leukocyte Surface Antigen Leu-23, Early Activation Antigen CD69, BL-AC/P26, GP32/28, MLR-3, AIM, EA1, C-Type Lectin Domain Family 2, Member C, Activation Inducer Molecule (AIM/CD69), C-Type Lectin Domain Family 2 Member C, Early Lymphocyte Activation Antigen, Activation Inducer Molecule, CD69 Antigen, CD69
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
969
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
CD69 overexpression
Melanoma
CD69 overexpression
Melanoma
PD1 inhibitor
Sensitive: C3 – Early Trials
PD1 inhibitor
Sensitive
:
C3
PD1 inhibitor
Sensitive: C3 – Early Trials
PD1 inhibitor
Sensitive
:
C3
CD69 overexpression
Melanoma
CD69 overexpression
Melanoma
PD-L1 inhibitor
Sensitive: C3 – Early Trials
PD-L1 inhibitor
Sensitive
:
C3
PD-L1 inhibitor
Sensitive: C3 – Early Trials
PD-L1 inhibitor
Sensitive
:
C3
CD69 overexpression
Lung Cancer
CD69 overexpression
Lung Cancer
PD1 inhibitor
Sensitive: C3 – Early Trials
PD1 inhibitor
Sensitive
:
C3
PD1 inhibitor
Sensitive: C3 – Early Trials
PD1 inhibitor
Sensitive
:
C3
CD69 overexpression
Lung Cancer
CD69 overexpression
Lung Cancer
PD-L1 inhibitor
Sensitive: C3 – Early Trials
PD-L1 inhibitor
Sensitive
:
C3
PD-L1 inhibitor
Sensitive: C3 – Early Trials
PD-L1 inhibitor
Sensitive
:
C3
CD69 overexpression
Chronic Lymphocytic Leukemia
CD69 overexpression
Chronic Lymphocytic Leukemia
bendamustine
Resistant: D – Preclinical
bendamustine
Resistant
:
D
bendamustine
Resistant: D – Preclinical
bendamustine
Resistant
:
D
CD69 overexpression
Chronic Lymphocytic Leukemia
CD69 overexpression
Chronic Lymphocytic Leukemia
ibrutinib + idelalisib
Sensitive: D – Preclinical
ibrutinib + idelalisib
Sensitive
:
D
ibrutinib + idelalisib
Sensitive: D – Preclinical
ibrutinib + idelalisib
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.